Covid-19 Sample Collection Kits Market By Product (Swabs (Nasopharyngeal (NP) Swabs, Oropharyngeal (OP) Swabs, and Others), Viral Transport Media, Blood Collection Kits, and Other Consumables), By Site of Collection (Hospitals & Clinics and Home Test), By Application (Diagnostics and Research), and By Region - Trends, Analysis, and Forecast till 2030

Covid-19 Sample Collection Kits Market accounted for USD 2.4 Billion in 2020 and is estimated to be USD 3.5 Billion by 2029 and is anticipated to register a CAGR of 4.2%.

The U.S. Food and Drug Administration has approved an at-home sample collection kit which can be delivered to specified laboratories for COVID-19 diagnostic testing. Further, the FDA has specially issued an emergency use authorization (EUA) to Everlywell, Inc. for the Everlywell COVID-19 Test Home Collection Kit. Everlywell’s kit is sanctioned to be used by individuals at home who have been screened using an online questionnaire that is revised by a health care provider. This Everlywell’s authorized kit enables an individual to self-collect a nasal sample at home. Two COVID-19 diagnostic tests has also been authorized by FDA, performed at specific laboratories, for use with samples collected using the Everlywell COVID-19 Test Home Collection Kit. Moreover, further tests may be authorized for use with the Everlywell at-home collection kit in future.

Rising initiatives by government bodies

The COVID-19 outbreak has severely affected various domains, one of such is Viral Transport Media (VTM) owing to high demand for SARS-CoV-2 RT-PCR testing across the world. Various companies as well as governments of several countries are rapidly scaling-up VTM production to meet the challenges in coronavirus testing. For instance, COPAN Diagnostics has recently enhanced its production line to fulfill the large volumes of orders. Furthermore, FDA and the Federal Emergency Management are working with various suppliers to meet the demand for VTM.

Growth in business operations by emerging and small sized players

A considerable number of key players from other sectors are involved in helping the government to overcome the shortage of medical sterile swabs. According to the data reported on May 2020, by Royal DSM, a nutrition, health, and materials company, entered the swab manufacturing market to combat the shortage of specimen collection products in the Netherlands. The company is first time generating swabs to fulfill the nation’s testing needs. Further, they are also donating 11 tons of material required for swab production in the country.

However, technical and clinical-related challenges might hamper growth of the global market to a certain extent.

The global Covid-19 sample collection kits market is segmented based on product, site of collection, application, and region.

On the basis of product, the global covid-19 sample collection kits market is segmented into swabs (nasopharyngeal (NP) swabs, oropharyngeal (OP) swabs, and others), viral transport media, blood collection kits, and other consumables. Based on site of collection, the target market is segmented into hospitals & clinics and home test. On the basis of application, the target market is segmented into diagnostics and research.

On region the global Covid-19 sample collection kits market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is expected to lead the market and estimate for about 35% revenue share in 2020. This is mainly attributed due to large number of coronavirus cases in the European region coupled with high volume of swabs tested in Germany. Asia Pacific is expected to register lucrative growth in the coming years owing to efforts adopted by home-grown companies to enlarge their offerings. For instance, in March 2020, Singapore-based Lucence Diagnostics Pte Ltd. introduced improved sample collection kit to overcome the impact of COVID-19.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global covid-19 sample collection kits market report based on product, site of collection, application, and region.

Global Covid-19 Sample Collection Kits Market, By Product:

• Swabs

• Nasopharyngeal (NP) Swabs
• Oropharyngeal (OP) Swabs
• Others

• Viral Transport Media
• Blood Collection Kits
• Other Consumables

Global Covid-19 Sample Collection Kits Market, By Site of Collection:

• Hospitals & Clinics
• Home Test

Global Covid-19 Sample Collection Kits Market, By Application:

• Diagnostics
• Research

Global Covid-19 Sample Collection Kits Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating in the global covid-19 sample collection kits market includes Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Puritan Medical Products, Becton, Dickinson and Company, COPAN Diagnostics, Lucence Diagnostics Pte Ltd., Hardy Diagnostics, HiMedia Laboratories, VIRCELL S.L., and BNTX Inc. Companies are continuously rising the production and supply of specimen collection kits. The volume of swabs coming from COPAN Diagnostics, Italy, in U.S. is constantly growing. In March 2020, about 6 tons of swabs were imported and 4.5 tons of swabs in January 2020 from COPAN to the U.S. ports.

• Thermo Fisher Scientific, Inc.
• Laboratory Corporation of America Holdings
• Puritan Medical Products
• Becton, Dickinson and Company
• COPAN Diagnostics
• Lucence Diagnostics Pte Ltd.
• Hardy Diagnostics
• BNTX Inc.
• HiMedia Laboratories
• VIRCELL S.L.